MedTrace Logo

Litramine in Weight Maintenance

NCT01505387 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2015-06-01

Study results available
· View outcomes & findings →

Summary

The effect of Litramine on weight loss has previously been studied during a 12-week intervention period with promising results. The present study looks into the effect of weight maintenance using Litramine following initial weight loss, for a longer period of 24 weeks.

Conditions

Interventions

DIETARY_SUPPLEMENT

Litramine

Fibre complex of plant origin in tablet form 2 tablets 3 times daily (oral consumption, after meal)

DIETARY_SUPPLEMENT

Placebo

Identical to Litramine tablets 2 tablets 3 times daily (oral consumption, after meal)

Sponsors & Collaborators

  • InQpharm Group

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2012-09-30
Completion
2012-09-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01505387 on ClinicalTrials.gov